Seeking Alpha

John H. Ford

 
View as an RSS Feed
View John H. Ford's Articles BY TICKER:
  • Why Oculus Could Trade Higher Within 2 Weeks
    Mon, Mar. 17 OCLS 126 Comments

    Summary

    • The Ruthigen IPO will add an immediate 46% to 100% increase to Oculus’s valuation.
    • Oculus and Ruthigen are undervalued, which should amplify share price appreciation.
    • Positive clinical data provides high probability of FDA approvals.
    • Oculus and Ruthigen own the patents to a technology that could revolutionize how infections are prevented and treated.
  • Why Finjan Could Go From $6 To $15
       • Thu, Jan. 23 FNJN 46 Comments
  • Senesco: Near-Term Catalyst Could Double Shareprice
       • Dec. 27, 2013 SVON 32 Comments
  • Opko's Lead Drug Could Double The Company's Valuation
    Dec. 5, 2013 OPK 47 Comments
  • Opko's Billionaire CEO Invested In ChromaDex
       • Dec. 4, 2013 CDXC 21 Comments
  • 22nd Century Is Worth Twice Today's Shareprice
       • Nov. 19, 2013 XXII 9 Comments
  • Opko And Its Billionaire CEO Invested In Biozone
    Editors' Pick • Sep. 26, 2013 COCP 34 Comments
  • Pershing Gold: Near-term Catalyst Could Provide 50% Upside
    Sep. 19, 2013 PGLC 38 Comments
  • Senesco's Extreme Undervaluation Provides Multi-Bagger Opportunity
       • Aug. 6, 2013 SVON 31 Comments
  • Why Marathon's Share Price Could Double This Year
       • Jul. 23, 2013 MARA 18 Comments
  • Is MGT About To Receive A Big Settlement?
    Apr. 11, 2013 MGT 21 Comments
  • Oculus And NovaBay: 100% Upside Potential
    Editors' Pick • Apr. 1, 2013 OCLS, NBY 67 Comments
  • MusclePharm Hits A Home Run
    Editors' Pick • Mar. 27, 2013 MSLP 14 Comments
  • Will Apple Get Its Mojo Back?
    Feb. 6, 2013 AAPL 60 Comments
  • Opko's Billionaire CEO Invests In MusclePharm
    Jan. 28, 2013 OPK 15 Comments
  • Medbox Short Could Provide A 50% Return
    Editors' Pick • Jan. 16, 2013 MDBX 22 Comments
  • Why MusclePharm Could Go From $4 To $20
    Dec. 19, 2012 MSLP 42 Comments
  • Internet Patents Corporation: Large Upside Potential, Limited Risk
       • Nov. 28, 2012 PTNT 16 Comments
  • Why MGT Lawsuit Could Provide A 2X Near-Term Return
    Nov. 5, 2012 MGT 10 Comments
  • Facebook Lawsuit Could Send Document Security Systems' Share Price Soaring
    Editors' Pick • Oct. 8, 2012 DSS 17 Comments
  • Opko's 4KScore Could Generate Over $1.8 Billion Annually
    Editors' Pick • Oct. 3, 2012 OPK 28 Comments
  • Near-Term Catalyst Could Drive ChromaDex Shares Higher
    Editors' Pick • Sep. 14, 2012 CDXC 41 Comments
  • Why Neuralstem Could Provide A 10x Return
    Sep. 11, 2012 CUR 28 Comments
  • Vringo Prevails Over AOL, Google Could Be Next
    Aug. 6, 2012 VRNG 22 Comments
  • Vringo's Stout Trumps 13 Tech Giants In NTP Patent Suit
    Jul. 25, 2012 VRNG 25 Comments
  • Google Settlement Could Drive Vringo Shares Above $30
    Editors' Pick • Jul. 23, 2012 VRNG 41 Comments
  • VirnetX Prevails Over Apple
    May. 3, 2012 VHC 14 Comments
  • Large Market Opportunity Emerges For Oculus Technology
    Mar. 27, 2012 OCLS 11 Comments
  • Apple, Cisco Or Siemens Should Just Buy VirnetX
    Mar. 7, 2012 VHC 20 Comments
  • $10 Billion Market Opportunity For Oculus
    Feb. 9, 2012 OCLS 17 Comments
  • Isoray: A Perfect Acquisition For Johnson & Johnson Or Pfizer
    Nov. 22, 2011 ISR 5 Comments
  • Isoray: Impressive 98% Success Treating Prostate Cancer
    Nov. 17, 2011 ISR 6 Comments